Lannett Company announced it has received FDA approval for its Abbreviated New Drug Application (ANDA) for Diazepam Oral Solution (Concentrate), the generic version of Roxane’s Diazepam Intensol.
Diazepam oral solution, a Schedule IV controlled drug, is a concentrated benzodiazepine solution indicated for the treatment of anxiety, as adjunct treatment for skeletal muscle spasm, and as adjunct treatment in convulsive disorders.
RELATED: Psychiatric Disorders Resource Center
Diazepam Oral Solution (Concentrate) is available in a 5mg/mL strength.
For more information, call (215) 333-9000 or visit Lannett.com.
